Encora Therapeutics Patents

Patent portfolio assigned to Encora Therapeutics (verified via public assignee records). Estimated patent count: 1. Encora Therapeutics (Boston, MA; MIT spinout) makes the Encora X1 wrist-worn neurostimulation wearable for essential tremor; FDA 510(k) cleared Feb 2026. Patent application US20220008283A1 'Apparatus and Method for Reduction of Neurological Movement Disorder Symptoms Using Wearable Device' lists assignee Encora, Inc. (inventors match the tremor device), so has_patents=true (at least 1; full count not confirmable as Google Patents assignee-query endpoint was unavailable). Cala Health is the principal named/known competitor in wrist-worn essential-tremor neuromodulation. No named customers.